StockClub
SPRYARS Pharmaceuticals, Inc.$ --
ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc.

SPRY

$ -

-

You can review balance sheet highlights, composition, equity ratio trends, and annual balance sheet line items.

account_balanceBalance Sheet (BS) Summary

2025/12 Filed: 2026-03-09

Total Assets

account_balance
327.7M USD
No comparison

Shareholders' Equity

savings
114.3M USD
No comparison

Equity Ratio

pie_chart
34.9%
No comparison

Book Value Per Share

paid
1.16USD
No comparison

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %
403020100
2021
2022
2023
2024
2025

Balance Sheet Details

Item
2018
2019
2020
2021
2022
2023
2024
2025
Cash
Cash and Equivalents
Short-term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
41.32M
41.32M
203.67M
25.35M
8.37M
6.19M
284.90M
Goodwill
Intangible Assets
Property, Plant and Equipment
Property, Plant and Equipment Net
Long-term Investments
Other Assets
Other Non-current Assets
Net Tangible Assets
Non-current Assets Total
Total Assets
0
14.45M
2.46M
2.46M
0
0
25.84M
313.20M
42.76M
327.65M
Accounts Payable
Short-term Debt
Short/Current Long-term Debt
Current Deferred Revenue
Other Current Liabilities
Total Current Liabilities
5.72M
588,000
588,000
0
32.83M
39.15M
Long-term Debt
Long-term Debt Total
Capital Lease Obligations
Other Non-current Liabilities
Net Debt
Non-current Liabilities Total
Total Liabilities
96.37M
96.96M
0
76.75M
55.65M
174.25M
213.39M
Common Stock
Common Stock Shares Outstanding
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Other Stockholder Equity
Treasury Stock
Total Stockholder Equity
10,000
98.57M
408.73M
-294.60M
125,000
0
0
114.26M

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.